BackBioAffinity Technologies- Warrants(23/06/2027) Overview

BioAffinity Technologies- Warrants(23/06/2027) Current Assets

Track BioAffinity Technologies- Warrants(23/06/2027)'s current assets ($3.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.87M
131.62% YoYΔ $2.20M vs prior year quarter

Peer trimmed avg / median

Loading

BioAffinity Technologies- Warrants(23/06/2027) Current Assets History

Loading

BioAffinity Technologies- Warrants(23/06/2027) vs. peers: Current Assets Comparison

Loading

BioAffinity Technologies- Warrants(23/06/2027) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioAffinity Technologies- Warrants(23/06/2027) (BIAFW) FAQ

BioAffinity Technologies- Warrants(23/06/2027) (BIAFW) currently reports a current assets of $3.9M as of June 2026. That compares with $1.7M in the prior-year period — up 131.6% year over year. Use the charts on this page to explore BioAffinity Technologies- Warrants(23/06/2027)'s current assets history and peer comparisons.

BioAffinity Technologies- Warrants(23/06/2027)'s current assets increased from $1.7M to $3.9M — a 131.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioAffinity Technologies- Warrants(23/06/2027) reported $3.9M in current assets as of June 2026. That compares with $1.7M in the prior-year period — up 131.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $3.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioAffinity Technologies- Warrants(23/06/2027), and consider following BIAFW for alerts when major investors trade the stock.